Adamed Group

Adamed Group, founded in 2010, is a pharmaceutical company that includes Adamed, Pabianickie Zakłady Farmaceutyczne Polfa, and Adamed Consumer Healthcare among other entities. The group operates in the healthcare industry, focusing on pharmaceuticals and consumer healthcare products. Its primary business activities revolve around research, development, production, and distribution of pharmaceuticals and healthcare solutions. With a diverse portfolio of products and services, Adamed Group aims to improve the quality of life and well-being of patients by providing innovative and high-quality healthcare solutions.

Marcin Szczecinski

Investment Manager

4 past transactions

Inuru

Series A in 2023
Inuru is a Berlin-based technology company that develops and manufactures organic light-emitting diode OLED printing technology to create paper-thin lighting and displays. Its on-demand printing enables low-cost OLED labels and illuminated surfaces for packaging, advertising, and print applications, adding light to surfaces using standard manufacturing processes. The company operates a fully automated OLED manufacturing line in Germany. Founded in 2016, Inuru aims to expand into clothing and medical applications and serves customers such as Coca-Cola and other brands.

Apeiron Synthesis

Seed Round in 2022
Apeiron Synthesis specializes in developing a wide range of catalysts for diverse applications such as pharmaceuticals, flavors and fragrances, polymers, and rubber production. They offer a broad portfolio of patented and patent-pending catalysts that cater to various processes using metathesis, providing tailored solutions throughout the research and development, implementation, and production stages.

Goodsleeper

Pre Seed Round in 2022
Goodsleeper is a pioneering sleep medicine application focused on enhancing sleep quality through cognitive behavioral therapy for insomnia (CBT-I). Recognized as the primary evidence-based treatment for insomnia, CBT-I offers more effective results than traditional sleep medications by addressing the underlying factors contributing to sleep disturbances. Through its application, Goodsleeper provides users with a structured approach to implementing CBT-I techniques, enabling them to analyze their sleep issues and develop personalized sleep improvement plans. The application also incorporates digital tools to facilitate the practical application of these therapeutic methods, allowing individuals to safely and effectively manage their insomnia.

Telemedi

Series A in 2021
Founded in 2014, Telemedi specializes in digital healthcare solutions. Their platform offers telemedicine, automated triage using AI, remote medical device monitoring, and API integrations for businesses.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.